Stocks experiencing significant discounts of up to -42%: is a reversal in these underperforming stocks imminent?
In a Rough Start for 2025, S&P 500 Stocks Offer Investment Opportunities
The ongoing trade crisis is causing some pain for stocks in the S&P 500, particularly for companies like Deckers Outdoor and Moderna. But is this a sign of distress or a golden opportunity for savvy investors?
Deckers Outdoor: Bottom of the Pack
No stock in the S&P 500 has had a worse start to 2025 than Deckers Outdoor, which has lost a staggering 42% since the year began. Despite reporting a 17% growth in revenue in the last quarter of the previous year and anticipating another 15% growth this year, analysts remain unimpressed and investors are less than optimistic about the footwear business in the current economic climate. With the new Trump tariffs looming, the impact could wipe out the company’s growth projections in the coming months. Nonetheless, the stock is now cheaper than it was a few months ago, making it tempting for some. However, it’s crucial to keep a watchful eye before jumping in.
Moderna: Long-Term Potential
Not far behind, Moderna finds itself in the second-to-last spot. The biotech company has suffered a 34% loss since the beginning of the year, much like BioNTech. The loss of COVID-19 vaccine revenues seems to be the main culprit. But despite the short-term market pessimism, Moderna's advanced mRNA technology offers a promising future. With potential applications in cancer treatments on the horizon, this might be a stock worth holding onto for the long run. However, in the short and medium term, expect volatility. Recent recommendations from U.S. Health Minister Robert F. Kennedy, known for his opposition to vaccinations, could contribute to this.
Your portfolio may also benefit from exploring other potential turnaround candidates in the Reversal Index from BÖRSE ONLINE.
Further Reading:- Tesla's stock is at its worst in years: Is it time to dump it from your portfolio?- Perfect entry point for cryptocurrencies? XRP, Ethereum, Solana, Cardano
Disclosure: The price of the financial instruments is derived from an index as the underlying. Boersenmedien AG has developed this index and holds the rights to it. Boersenmedien AG has entered into a cooperation agreement with the issuer of the displayed securities, granting the issuer a license to use the index. In return, Boersenmedien AG receives remuneration from the issuer.
In 2025, struggling stocks within the S&P 500 index, such as Deckers Outdoor and Moderna, present unusual opportunities due to the broader market challenges and economic uncertainties affecting the index.
Market Context in 2025
The S&P 500 has seen a decline of about 6% since the start of the year, driven by economic concerns and trade policy shocks, such as unexpected tariff increases announced in April 2025. These measures have led to reassessments of recession risks and corporate earnings potential, causing heightened market volatility and fears of an impending bear market. Though inflation pressures have eased compared to the previous year, the Federal Reserve's aggressive monetary policies have continued to weigh on economic growth and investor sentiment.
Unique Investment Opportunities in Struggling S&P 500 Stocks
- Potential for Value Investing and Mean Reversion: Stocks like Deckers Outdoor and Moderna, which have underperformed amid these macroeconomic headwinds, may be trading below their intrinsic value due to broad market sell-offs rather than company-specific fundamental weaknesses.
- Sector-Specific Growth Prospects: Moderna, operating in biotechnology and pharmaceuticals, offers opportunities due to the continued demand for healthcare innovation and potential breakthroughs in vaccines or therapies. Deckers Outdoor might exhibit upside potential if consumer spending recovers or if the company successfully navigates supply chain or cost challenges that have pressured profitability.
- Portfolio Diversification and Risk Management: Given the uncertain economic outlook, including tariff impacts that have intensified recession fears, investing selectively in struggling stocks with solid fundamentals can help diversify risk. These stocks may exhibit lower correlation to some broader economic segments under pressure, offering strategic entry points for long-term investors.
- Contrarian Investment Strategy: Market downturns like the current one provide fertile ground for contrarian investors seeking bargains. Stocks beaten down due to macro shocks but with strong future growth catalysts often outperform as markets recover.
- Enhanced Due Diligence and Active Management: Due to heightened volatility and risk, active management and deep fundamental analysis become crucial. Investors can exploit inefficiencies in pricing for companies like Deckers Outdoor and Moderna. Monitoring company-specific developments, such as Moderna’s progress on drug development or Deckers’ earnings outlook and cost management, can help time entry and exit points.
In conclusion, while the S&P 500 faces headwinds from tariffs, cautious consumer sentiment, and economic uncertainty, struggling stocks like Deckers Outdoor and Moderna offer investment opportunities due to potential undervaluation, sector-specific growth dynamics, and contrarian appeal. These opportunities require careful risk assessment and active management, particularly in a market environment that may not have bottomed yet according to some analyses.
Investing in the stock-market could present unique opportunities, as struggling S&P 500 stocks like Deckers Outdoor and Moderna might be undervalued due to broader market challenges and economic uncertainties. This situation could prove beneficial for value investing, mean reversion, and sector-specific growth prospects, as well as portfolio diversification and risk management. However, given the volatile market conditions, active management and enhanced due diligence are essential to exploit pricing inefficiencies and time entry and exit points effectively.
